Title: Tumor Antigen-/Cytokine-Pulsed dendritic cells in therapy against lymphoma
| dc.contributor.author | Sumit K. Hira | |
| dc.contributor.author | Deepak Verma | |
| dc.contributor.author | Partha P. Manna | |
| dc.date.accessioned | 2026-02-07T06:01:52Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Adoptive cell therapy using dendritic cells (DCs) is a strategy to deliver tumor antigens in cancer immunotherapy. Co-delivery of antigens to DC with essential components like genes encoding cytokines, chemokines, and other molecules or stimulation with recombinant cytokines is a potential method for designing an effective tumor vaccine protocol. Here, we describe the stimulation of purified splenic- or bone marrow-derived DC with recombinant interleukin-15 (IL-15) in the presence of intact soluble antigen from metastatic lymphoma tumor cells in an experimental animal model. © Springer Science+Business Media New York 2014. | |
| dc.identifier.doi | 10.1007/978-1-4939-0345-0_6 | |
| dc.identifier.issn | 10643745 | |
| dc.identifier.uri | https://doi.org/10.1007/978-1-4939-0345-0_6 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/26642 | |
| dc.publisher | Humana Press Inc. | |
| dc.subject | Adoptive cell transfer | |
| dc.subject | Antigens | |
| dc.subject | Cytokines | |
| dc.subject | Dendritic cells | |
| dc.subject | IL-15 | |
| dc.subject | Kaplan-Meier survival curve | |
| dc.subject | Tumor metastasis | |
| dc.title | Tumor Antigen-/Cytokine-Pulsed dendritic cells in therapy against lymphoma | |
| dc.type | Publication | |
| dspace.entity.type | Article |